HLB Co. Ltd (028300) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.024x

Based on the latest financial reports, HLB Co. Ltd (028300) has a cash flow conversion efficiency ratio of -0.024x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-11.08 Billion ≈ $-7.51 Million USD) by net assets (₩452.86 Billion ≈ $306.90 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See HLB Co. Ltd defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

HLB Co. Ltd - Cash Flow Conversion Efficiency Trend (2010–2024)

This chart illustrates how HLB Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

HLB Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of HLB Co. Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Northland Power Inc.
TO:NPI
0.113x
TFS Financial Corporation
NASDAQ:TFSL
0.031x
Rush Enterprises A Inc
NASDAQ:RUSHA
0.038x
Anhui Zhongding Sealing Parts Co Ltd
SHE:000887
0.040x
Dropbox Inc
NASDAQ:DBX
-0.131x
New Hope Liuhe Co Ltd
SHE:000876
0.090x
ABSA Bank Limited
JSE:ABSP
0.127x
AutoStore Holdings Ltd
OL:AUTO
0.048x

Annual Cash Flow Conversion Efficiency for HLB Co. Ltd (2010–2024)

The table below shows the annual cash flow conversion efficiency of HLB Co. Ltd from 2010 to 2024. For the full company profile with market capitalisation and key ratios, see 028300 market cap overview.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 ₩576.57 Billion
≈ $390.73 Million
₩-114.31 Billion
≈ $-77.47 Million
-0.198x -3.41%
2023-12-31 ₩582.25 Billion
≈ $394.58 Million
₩-111.63 Billion
≈ $-75.65 Million
-0.192x -97.86%
2022-12-31 ₩637.94 Billion
≈ $432.32 Million
₩-61.82 Billion
≈ $-41.89 Million
-0.097x +22.86%
2021-12-31 ₩435.96 Billion
≈ $295.44 Million
₩-54.77 Billion
≈ $-37.11 Million
-0.126x -6.64%
2020-12-31 ₩479.75 Billion
≈ $325.12 Million
₩-56.51 Billion
≈ $-38.30 Million
-0.118x +55.24%
2019-12-31 ₩184.89 Billion
≈ $125.30 Million
₩-48.66 Billion
≈ $-32.97 Million
-0.263x -57.63%
2018-12-31 ₩174.68 Billion
≈ $118.38 Million
₩-29.16 Billion
≈ $-19.76 Million
-0.167x +32.42%
2017-12-31 ₩77.24 Billion
≈ $52.35 Million
₩-19.08 Billion
≈ $-12.93 Million
-0.247x -115.97%
2016-12-31 ₩88.75 Billion
≈ $60.14 Million
₩-10.15 Billion
≈ $-6.88 Million
-0.114x -1436.44%
2015-12-31 ₩84.65 Billion
≈ $57.37 Million
₩724.49 Million
≈ $490.97K
0.009x +104.96%
2014-12-31 ₩23.02 Billion
≈ $15.60 Million
₩-3.97 Billion
≈ $-2.69 Million
-0.173x -601.71%
2011-12-31 ₩21.19 Billion
≈ $14.36 Million
₩728.78 Million
≈ $493.89K
0.034x +164.06%
2010-12-31 ₩23.31 Billion
≈ $15.79 Million
₩303.53 Million
≈ $205.70K
0.013x --

About HLB Co. Ltd

KQ:028300 Korea Biotechnology
Market Cap
$4.30 Billion
₩6.34 Trillion KRW
Market Cap Rank
#4006 Global
#100 in Korea
Share Price
₩48350.00
Change (1 day)
+6.26%
52-Week Range
₩37000.00 - ₩68200.00
All Time High
₩120800.00
About

HLB Co., Ltd. manufactures and constructs lifeboats and glass fiber pipes in South Korea and internationally. It engages in the repair and inspection of lifeboats; fabrication and installation of pipes; development and manufacturing of biopharmaceuticals products, such as anti-cancer drugs; and manufacture and sale of medical devices, as well as manufacture and sale of quasi-drugs products, inclu… Read more